Amneal Pharmaceuticals, Inc. (AMRX)
20.30
+0.23
(+1.15%)
USD |
NASDAQ |
Oct 02, 16:00
20.44
+0.14
(+0.69%)
After-Hours: 20:00
Amneal Pharmaceuticals Gross Profit Margin (Quarterly) : 42.01% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 42.01% |
| March 31, 2026 | 44.31% |
| December 31, 2025 | 36.50% |
| September 30, 2025 | 34.92% |
| June 30, 2025 | 39.51% |
| March 31, 2025 | 36.80% |
| December 31, 2024 | 35.98% |
| September 30, 2024 | 38.37% |
| June 30, 2024 | 35.62% |
| March 31, 2024 | 36.11% |
| December 31, 2023 | 36.62% |
| September 30, 2023 | 37.50% |
| June 30, 2023 | 36.73% |
| March 31, 2023 | 31.96% |
| December 31, 2022 | 36.20% |
| September 30, 2022 | 35.73% |
| June 30, 2022 | 36.76% |
| March 31, 2022 | 35.08% |
| December 31, 2021 | 35.09% |
| September 30, 2021 | 37.68% |
| June 30, 2021 | 39.71% |
| March 31, 2021 | 38.85% |
| December 31, 2020 | 32.76% |
| September 30, 2020 | 31.96% |
| June 30, 2020 | 31.20% |
| Date | Value |
|---|---|
| March 31, 2020 | 37.10% |
| December 31, 2019 | 31.20% |
| September 30, 2019 | 29.23% |
| June 30, 2019 | 26.75% |
| March 31, 2019 | 30.57% |
| December 31, 2018 | 39.12% |
| September 30, 2018 | 43.63% |
| June 30, 2018 | 43.09% |
| March 31, 2018 | 52.54% |
| December 31, 2017 | 51.61% |
| September 30, 2017 | 53.00% |
| June 30, 2017 | 47.61% |
| March 31, 2017 | |
| December 31, 2016 | 34.96% |
| September 30, 2016 | 46.04% |
| June 30, 2016 | 43.16% |
| March 31, 2016 | 46.11% |
| December 31, 2015 | 40.69% |
| September 30, 2015 | 43.40% |
| June 30, 2015 | 39.62% |
| March 31, 2015 | 41.39% |
| December 31, 2014 | 46.35% |
| September 30, 2014 | 53.44% |
| June 30, 2014 | 58.35% |
| March 31, 2014 | 50.98% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Liquidia Corp. | 93.10% |
| Eli Lilly & Co. | 85.78% |
| Johnson & Johnson | 68.73% |
| Merck & Co., Inc. | 71.51% |
| Viatris, Inc. | 41.92% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 1.46K% |
| Return on Assets | 5.98% |
| Return on Invested Capital | 7.96% |
| Profit Margin (Quarterly) | 8.74% |
| Operating Margin (Quarterly) | 18.43% |
| Return on Net Operating Assets | 6.51% |